ATE264093T1 - Sojazubereitungen und deren verwendung zur gesundheitsförderung - Google Patents

Sojazubereitungen und deren verwendung zur gesundheitsförderung

Info

Publication number
ATE264093T1
ATE264093T1 AT99938755T AT99938755T ATE264093T1 AT E264093 T1 ATE264093 T1 AT E264093T1 AT 99938755 T AT99938755 T AT 99938755T AT 99938755 T AT99938755 T AT 99938755T AT E264093 T1 ATE264093 T1 AT E264093T1
Authority
AT
Austria
Prior art keywords
present
soy
formulation
formulations
pharmacological compositions
Prior art date
Application number
AT99938755T
Other languages
English (en)
Inventor
Aaron Tabor
Original Assignee
Aaron Tabor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26786272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE264093(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aaron Tabor filed Critical Aaron Tabor
Application granted granted Critical
Publication of ATE264093T1 publication Critical patent/ATE264093T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
AT99938755T 1998-07-16 1999-07-16 Sojazubereitungen und deren verwendung zur gesundheitsförderung ATE264093T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9298598P 1998-07-16 1998-07-16
US10579798P 1998-10-27 1998-10-27
PCT/US1999/016203 WO2000003684A2 (en) 1998-07-16 1999-07-16 Soy formulations and their use for promoting health

Publications (1)

Publication Number Publication Date
ATE264093T1 true ATE264093T1 (de) 2004-04-15

Family

ID=26786272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938755T ATE264093T1 (de) 1998-07-16 1999-07-16 Sojazubereitungen und deren verwendung zur gesundheitsförderung

Country Status (9)

Country Link
US (2) US6482448B2 (de)
EP (1) EP1037590B1 (de)
CN (1) CN1184895C (de)
AT (1) ATE264093T1 (de)
AU (1) AU773631B2 (de)
CA (1) CA2313789A1 (de)
DE (1) DE69916414T2 (de)
ES (1) ES2220102T3 (de)
WO (1) WO2000003684A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11513390A (ja) * 1995-10-06 1999-11-16 アーチ デベロップメント コーポレイション 細胞殺傷のウイルス増強のための方法および組成物
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
RU2002111408A (ru) * 1999-10-18 2004-05-20 Мусклетеч Ресеч Энд Девелопмент Инк. (Ca) Пищевая добавка для увеличения мышечной массы и силы
EP2330092A3 (de) * 2000-02-01 2012-07-25 Stevia APS Arzneimittel enthaltend Steviol oder Isosteviol zur Behandlung des Insulinunabhängigen Diabetes Mellitus, Bluthochdruck und/oder des metabolischen Syndroms
WO2001074345A2 (en) * 2000-03-31 2001-10-11 Jonathan Ingram Isoflavones for treatment of obesity
FR2813790B1 (fr) * 2000-09-11 2004-03-12 Dolisos Lab Preparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques
US7429399B2 (en) * 2001-06-18 2008-09-30 Solae, Llc Modified oilseed material
US20040219281A1 (en) * 2000-11-21 2004-11-04 Cargill, Incorporated Modified oilseed material
US20020160079A1 (en) * 2001-02-28 2002-10-31 Kim Tae-Hyun Koji produced from soybean hypocotyl, preparation method thereof, and soy hypocotyl products prepared from said koji
WO2002101023A2 (en) * 2001-06-13 2002-12-19 E.I. Du Pont De Nemours And Company A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
JP4475947B2 (ja) 2001-07-24 2010-06-09 カーギル インコーポレイテッド フェノール化合物の単離方法
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
PL370889A1 (en) * 2001-12-20 2005-05-30 Femmepharma, Inc. Vaginal delivery of drugs
ITMI20020665A1 (it) * 2002-03-29 2003-09-29 Marfarma S R L Composizioni fluide per uso vaginale
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
EP1578421A4 (de) * 2003-01-02 2009-04-22 Femmepharma Holding Co Inc Pharmazeutische präparate für diebehandlung von erkrankungen und pathologischen zuständen der brust
AU2007216882B2 (en) * 2003-01-02 2010-03-11 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatment of diseases and disorders of the breast
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US7022355B2 (en) * 2003-05-08 2006-04-04 Solae, Llc Composition and process for the production of a vegetable protein composition containing an alkaline earth metal salt
US7718813B2 (en) 2003-08-15 2010-05-18 Nature Pure Labs Sw, Inc. Hydrolysis and purification of active plant compounds suitable for topical application
US7763292B2 (en) * 2004-05-10 2010-07-27 Instituto Technologico Y De Estudios Superiores De Monterrey Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts
US20060009430A1 (en) * 2004-07-01 2006-01-12 Kelly Gregory J Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
US20060188548A1 (en) * 2004-12-14 2006-08-24 Mattson Peter H Satiety promoting beverage and use in a diet to moderate food consumption
CA2613788C (en) * 2005-06-29 2016-08-23 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
AU2007256718A1 (en) 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
EP2068853A2 (de) * 2006-09-15 2009-06-17 Stevia APS Behandlung von insulinresistenz oder erkrankungen im zusammenhang mit insulinresistenz mit bicyclo[3.2.1]octanen wie steviol und isosteviol
US20080153789A1 (en) * 2006-12-26 2008-06-26 Femmepharma Holding Company, Inc. Topical administration of danazol
EP2478901A3 (de) * 2007-02-14 2012-11-14 Mars Incorporated Neurogene Verbindungen
US20100068334A1 (en) * 2008-09-12 2010-03-18 Damon Randolph Race Medicinal Food and Beverage Compositions and Related Methods for Managing Acne in Humans
CA2736747C (en) * 2008-09-19 2018-02-27 Nestec S.A. Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US9775856B2 (en) * 2012-03-09 2017-10-03 Faculdade De Ciencias Da Universidade De Lisboa C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents
WO2021064107A1 (en) * 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864362A (en) 1970-05-27 1975-02-04 Chinoin Gyogyszer Es Vegyeszet Iso flavones
USRE40792E1 (en) * 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
TW274550B (de) 1992-09-26 1996-04-21 Hoechst Ag
AU6635994A (en) 1993-04-16 1994-11-08 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
US5506211A (en) 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5424331A (en) 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5523087A (en) 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
US5707630A (en) 1996-01-04 1998-01-13 Sabina International, Ltd. Herbal compound for relief of PMS through menopausal symptoms
DK0906029T3 (da) * 1996-04-09 2002-09-09 Du Pont Isoflavonberiget sojaproteinprodukt og fremgangsmåde til fremstilling heraf
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
JP2829387B2 (ja) 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
US5733926A (en) 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
US6083526A (en) 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en) 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US5942539A (en) 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
US6132795A (en) * 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material

Also Published As

Publication number Publication date
US20030021859A1 (en) 2003-01-30
US20020103223A1 (en) 2002-08-01
EP1037590A2 (de) 2000-09-27
CN1277540A (zh) 2000-12-20
ES2220102T3 (es) 2004-12-01
US6482448B2 (en) 2002-11-19
AU773631B2 (en) 2004-05-27
CN1184895C (zh) 2005-01-19
CA2313789A1 (en) 2000-01-27
AU5316899A (en) 2000-02-07
DE69916414D1 (de) 2004-05-19
WO2000003684A2 (en) 2000-01-27
EP1037590B1 (de) 2004-04-14
WO2000003684A3 (en) 2000-04-20
DE69916414T2 (de) 2005-05-19

Similar Documents

Publication Publication Date Title
DE69916414D1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
EP0903143A3 (de) Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
DE60029797D1 (de) Zusammensetzungen und therapeutische anwendungen von isoflavonen und deren analoga
PL368976A1 (en) Composition for lowering blood cholesterol
ATE253921T1 (de) Kombinationen aus calzium und vitamin d
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
AU5079600A (en) Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
DK1032363T3 (da) Leveringssystem med konjugeret linolsyre i kosmetiske præparater
DE60221367D1 (de) ZUSAMMENSETZUNG ZUR PRÄVENTION VON OSTEOPOROSE bestehend aus EINER KOMBINATION AUS ISOFLAVONEN UND POLYUNGESÄTTIGTEN FETTSÄUREN
BG106155A (en) Novel derivatives and analogues of galanthamin
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
IL141325A0 (en) Tan-1057 derivatives
BR0215124A (pt) Compostos e seus usos, composições farmacêutica e cosmética e uso cosmético de uma composição cosmética
ATE275409T1 (de) Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
MY135460A (en) Method of stimulating hair growth using benzopyrans
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE502004007506D1 (de) Formulierung auf phospholipidbasis
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
DE60214881D1 (de) Zubereitungen zur behandlung von lupus
BR9914895A (pt) Composições compreendendo uma mistura de bioflavonóis
WO2003040119A8 (fr) Inhibiteurs de l'angiogenese
ATE465158T1 (de) Anwendungen von tocopherolestern
UA37400A (uk) Збір лікарських рослин для харчової добавки "валеотон" і спосіб її приготування

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties